LIFE SCI ACQ II

Life Sci Acquisition 2 Corp, trading under the ticker SNCE, was a blank-check company sponsored by Life Sci Capital, LLC and focused on the life sciences and healthcare sector. The SPAC completed its initial public offering in 2021, targeting merger candidates in biotechnology, pharmaceuticals, and related life sciences industries. In March 2024, the company filed a Form 15-12G with the SEC, effective as of the filing date of March 25, 2024, terminating its registration and suspending its reporting obligations under Section 12(g) of the Securities Exchange Act. This filing marks the conclusion of SNCE's registered status as a public company. Visit SpacDesk and sign up for full data, filings history, and analytics on SNCE and hundreds of other SPAC transactions.